Duffull SB - Search Results

1

Identifying a therapeutic target for vancomycin against staphylococci in young infants.

Gwee A, Duffull SB, Daley AJ, Lim M, Germano S, Bilal H, Hall S, Curtis N, Zhu X. Gwee A, et al. Among authors: duffull sb. J Antimicrob Chemother. 2022 Feb 23;77(3):704-710. doi: 10.1093/jac/dkab469. J Antimicrob Chemother. 2022. PMID: 35037934

2

Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model.

Duffull SB, Begg EJ, Chambers ST, Barclay ML. Duffull SB, et al. Antimicrob Agents Chemother. 1994 Oct;38(10):2480-2. doi: 10.1128/AAC.38.10.2480. Antimicrob Agents Chemother. 1994. PMID: 7840593 Free PMC article.

3

An extended interval dosing method for gentamicin in neonates.

Stickland MD, Kirkpatrick CM, Begg EJ, Duffull SB, Oddie SJ, Darlow BA. Stickland MD, et al. Among authors: duffull sb. J Antimicrob Chemother. 2001 Dec;48(6):887-93. doi: 10.1093/jac/48.6.887. J Antimicrob Chemother. 2001. PMID: 11733474

4

Pharmacokinetic-Pharmacodynamic Model for the Effect of l-Arginine on Endothelial Function in Patients with Moderately Severe Falciparum Malaria.

Brussee JM, Yeo TW, Lampah DA, Anstey NM, Duffull SB. Brussee JM, et al. Among authors: duffull sb. Antimicrob Agents Chemother. 2015 Oct 19;60(1):198-205. doi: 10.1128/AAC.01479-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26482311 Free PMC article. Clinical Trial.

5

An evaluation of the operational model when applied to quantify functional selectivity.

Zhu X, Finlay DB, Glass M, Duffull SB. Zhu X, et al. Among authors: duffull sb. Br J Pharmacol. 2018 May;175(10):1654-1668. doi: 10.1111/bph.14171. Epub 2018 Mar 30. Br J Pharmacol. 2018. PMID: 29457969 Free PMC article.

6

An intact model for quantifying functional selectivity.

Zhu X, Finlay DB, Glass M, Duffull SB. Zhu X, et al. Among authors: duffull sb. Sci Rep. 2019 Feb 22;9(1):2557. doi: 10.1038/s41598-019-39000-z. Sci Rep. 2019. PMID: 30796256 Free PMC article.

7

Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB₁ receptors.

Zhu X, Finlay DB, Glass M, Duffull SB. Zhu X, et al. Among authors: duffull sb. Br J Pharmacol. 2019 Jul;176(14):2593-2607. doi: 10.1111/bph.14684. Epub 2019 May 21. Br J Pharmacol. 2019. PMID: 30945265 Free PMC article.

8

Defining Target Vancomycin Trough Concentrations for Treating Staphylococcus aureus Infection in Infants Aged 0 to 90 Days.

Gwee A, Cranswick N, McMullan B, Bolisetty S, Hunt RW, Curtis N, Duffull SB. Gwee A, et al. Among authors: duffull sb. JAMA Pediatr. 2019 Aug 1;173(8):791-793. doi: 10.1001/jamapediatrics.2019.1488. JAMA Pediatr. 2019. PMID: 31180478 Free PMC article.

9

Evaluation of the profiles of CB₁ cannabinoid receptor signalling bias using joint kinetic modelling.

Zhu X, Finlay DB, Glass M, Duffull SB. Zhu X, et al. Among authors: duffull sb. Br J Pharmacol. 2020 Aug;177(15):3449-3463. doi: 10.1111/bph.15066. Epub 2020 May 15. Br J Pharmacol. 2020. PMID: 32293708 Free PMC article.

10

Twice- and Thrice-daily Cephalexin Dosing for Staphylococcus aureus Infections in Children.

Gwee A, Autmizguine J, Curtis N, Duffull SB. Gwee A, et al. Among authors: duffull sb. Pediatr Infect Dis J. 2020 Jun;39(6):519-522. doi: 10.1097/INF.0000000000002646. Pediatr Infect Dis J. 2020. PMID: 32412727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page